FISH-based kit for detecting ALK gene translocations in lung and other malignancies. The test enables identification of ALK-positive tumors for appropriate therapeutic targeting.
Manufactured by
Guangzhou LBP Medicine Science & Technology Co.,Ltd.
China
Guangzhou LBP Medicine Science & Technology Co., Ltd, founded in 2005, is the first publicly listed company in China's pathological diagnosis sector (listed on SSE STAR Market in 2020). The company specializes in R&D and manufacturing of pathological diagnostic products, with core technologies including liquid-based cytology, PCR, FISH probe labeling, and IHC antibody screening. LBP holds 60+ patents including 15 invention patents, with 500+ registered products serving nearly 1,800 medical institutions nationwide. Products are CE certified and approved by BSI and Japan MHLW.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
TRUPCR Europe Ltd
United Kingdom · 18 relevant products
Shenzhen HaploX Biotechnology Co., Ltd.
China · 3 relevant products
PlexBio Co., Ltd.
Taiwan · 3 relevant products
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 112 closest product alternatives
TRUPCR Europe Ltd · United Kingdom
A diagnostic kit for detecting ALK gene fusions. Applied in solid tumour oncology for identifying anaplastic lymphoma kinase rearrangements in cancer samples.
Shenzhen HaploX Biotechnology Co., Ltd. · China
An in vitro diagnostic reagent kit for qualitative detection of EGFR and ALK gene mutations in non-small cell lung cancer (NSCLC). The kit has received Class III medical device registration certification from the National Medical Products Administration and is used for clinical diagnosis in hospitals nationwide.
Shenzhen HaploX Biotechnology Co., Ltd. · China
A reagent kit designed for the combined detection of human EGFR and ALK gene mutations. The kit is used for molecular testing to identify specific genetic mutations in patient samples.
109 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products